ai3Bio launches from stealth, Matchpoint's big raise for new autoimmune drug, layoffs at Foghorn and Enanta
Plus another Eli Lilly acquisition moves to Arsenal Yards
Triveni's New Digs, 99 Coolidge's Tenant Bonanza, and Remix's FDA Fast Track Designation
Plus Addgenes' new partnership, and Neumora and Acrivon's cash flow updates